Featured Research

from universities, journals, and other organizations

Strong Demand For HIV Meds After High-risk Sex

Date:
November 12, 2007
Source:
University of California - Los Angeles
Summary:
People who do not have HIV but seek antiretroviral medications following high-risk sexual encounters are very likely to complete the full month-long drug regimen, according to a new study. Moreover, there is a strong demand for publicly available post-exposure prophylaxis among high-risk populations. Based on these findings, the researchers recommend that post-exposure HIV prophylaxis be made available to citizens who have engaged in high-risk sex.

People who do not have HIV but seek antiretroviral medications following high-risk sexual encounters are very likely to complete the full monthlong drug regimen, according to a new UCLA AIDS Institute study. Moreover, there is a strong demand for publicly available post-exposure prophylaxis among high-risk populations in Los Angeles County.

Based on these findings, the researchers recommend that Los Angeles County make post-exposure HIV prophylaxis available to citizens who have engaged in high-risk sex, just as it has for health care workers who inadvertently find themselves at risk due to accidental needle sticks.

"We frame this as a social justice issue. People with means and health insurance plans do get post-exposure prophylaxis because they can pay for it," said Steven Shoptaw, professor of family medicine and psychiatry at the David Geffen School of Medicine at UCLA and a member of the UCLA AIDS Institute. "It is our belief that we have a responsibility to provide that level of protection to all our citizens. These data show that when this kind of prevention is made available, the at-risk community will access and use it."

Researchers based their conclusions on a study that followed 100 people who received HIV medications following unprotected, very high-risk sex. Each participant was given 28 days worth of lamivudine and zidovudine, as well as HIV tests and physical examinations, and was scheduled for a follow-up visit 26 weeks later. Participants were highly educated in general, 63 percent were gay and 95 percent were male.

Of the participants, 75 percent completed the monthlong drug treatment and none were found to have converted to HIV-positive status, the researchers said. Given that such a high percentage of patients completed the full drug regimen, UCLA researchers concluded that it would be feasible to develop a post-exposure prophylaxis plan for at-risk populations that could be implemented through Los Angeles County.

"We have 2,000-plus HIV infections in this county every year, and that rate has been stable for a number of years, which signifies that behavioral prevention has reached its peak," Shoptaw said. "Having post-exposure prophylaxis available may provide another arrow in the quiver to prevent new HIV infections."

The study is available on the website of the journal AIDS Care for free to nonsubscribers through Dec. 31. In addition to Shoptaw, study authors were Erin Rotheram-Fuller, Jason Wang, Ardis Moe, Raphael J. Landovitz and Cathy Reback of UCLA, and David E. Kanouse of the RAND Corp. Shoptaw is also affiliated with the Baltimore-based Friends Research Institute, and Reback is associated with the Van Ness Recovery House Prevention Division in Los Angeles.


Story Source:

The above story is based on materials provided by University of California - Los Angeles. Note: Materials may be edited for content and length.


Cite This Page:

University of California - Los Angeles. "Strong Demand For HIV Meds After High-risk Sex." ScienceDaily. ScienceDaily, 12 November 2007. <www.sciencedaily.com/releases/2007/11/071109100218.htm>.
University of California - Los Angeles. (2007, November 12). Strong Demand For HIV Meds After High-risk Sex. ScienceDaily. Retrieved September 23, 2014 from www.sciencedaily.com/releases/2007/11/071109100218.htm
University of California - Los Angeles. "Strong Demand For HIV Meds After High-risk Sex." ScienceDaily. www.sciencedaily.com/releases/2007/11/071109100218.htm (accessed September 23, 2014).

Share This



More Health & Medicine News

Tuesday, September 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Costs Keep Mounting

Ebola Costs Keep Mounting

Reuters - Business Video Online (Sep. 23, 2014) The WHO has warned up to 20,000 people could be infected with Ebola over the next few weeks. As Sonia Legg reports, the implications for the West African countries suffering from the disease are huge. Video provided by Reuters
Powered by NewsLook.com
WHO: Ebola Cases to Triple in Weeks Without Drastic Action

WHO: Ebola Cases to Triple in Weeks Without Drastic Action

AFP (Sep. 23, 2014) The number of Ebola infections will triple to 20,000 by November, soaring by thousands every week if efforts to stop the outbreak are not stepped up radically, the WHO warned in a study on Tuesday. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
5 Ways Men Can Prevent Most Heart Attacks

5 Ways Men Can Prevent Most Heart Attacks

Newsy (Sep. 23, 2014) No surprise here: A recent study says men can reduce their risk of heart attack by maintaining a healthy lifestyle, which includes daily exercise. Video provided by Newsy
Powered by NewsLook.com
Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins